| Authors: |
Kenny HA; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago, Chicago, Illinois., Ip CKM; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago, Chicago, Illinois., Kelliher L; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago, Chicago, Illinois., Samantaray T; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago, Chicago, Illinois., Kordylewicz K; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago, Chicago, Illinois., Hoffmann R; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago, Chicago, Illinois., Rauch S; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago, Chicago, Illinois., Malacrida B; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Skingsley SLP; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Balkwill FR; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Battistini C; Unit of Gynecological Oncology Research, European Institute of Oncology IRCCS, Milan, Italy., Cavallaro U; Unit of Gynecological Oncology Research, European Institute of Oncology IRCCS, Milan, Italy., Wiedemeyer WR; AbbVie Inc., North Chicago, Illinois., Lengyel E; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago, Chicago, Illinois. |
